Top News
Latest News
PARTNERSHIPS
20 Jan 2026
GSK-RAPT Deal Points to Pharma’s Biologic FutureINSIGHTS
19 Jan 2026
US Fermentation Push Signals a Shift in Drug Supply StrategyREGULATORY
15 Jan 2026
FDA Loosens CMC Rules to Speed Cell and Gene TherapiesPARTNERSHIPS
13 Jan 2026
Fermentation Partnerships Redefine Health Ingredients
Blockchain Gains Attention as Pharma Reconsiders Data Integrity
TECHNOLOGY
7 Jan 2026
Driven by ALCOA+ expectations, US pharma is exploring blockchain for data integrity. Proven in supply chains, its use in fermentation remains theoretical
PARTNERSHIPS
20 Jan 2026
GSK-RAPT Deal Points to Pharma’s Biologic Future
GSK’s RAPT acquisition shows how biologics, manufacturing muscle, and dealmaking are reshaping the next phase of pharma growth
INSIGHTS
19 Jan 2026
US Fermentation Push Signals a Shift in Drug Supply Strategy
Federal backing and Fermworx’s rise point to renewed focus on domestic fermentation as drugmakers rethink risk, scale, and supply chains
REGULATORY
15 Jan 2026
FDA Loosens CMC Rules to Speed Cell and Gene Therapies
FDA narrows manufacturing oversight for cell and gene therapies, aiming to speed development while keeping patient safety at the center
PARTNERSHIPS
13 Jan 2026
Fermentation Partnerships Redefine Health Ingredients
Precision fermentation alliances are stabilizing supply chains and speeding innovation across food, cosmetics, and nutrition
TECHNOLOGY
7 Jan 2026
Blockchain Gains Attention as Pharma Reconsiders Data Integrity
Driven by ALCOA+ expectations, US pharma is exploring blockchain for data integrity. Proven in supply chains, its use in fermentation rema...
PARTNERSHIPS
6 Jan 2026
Sanofi’s $2.2B Dynavax Bet Signals a Vaccine Power Shift
Sanofi’s Dynavax buyout underscores how US-based biologics manufacturing is becoming a strategic must-have for vaccine makers
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.